The Third Editorial Board Meeting of the journal Hepatoma Research (HR) was held in Xi’an on September 22rd, where the participants discussed in particular the future development of the journal and the current popular topics in liver cancer.
Invited were over 18 editorial board members with top academic backgrounds, including Professor Guang-Wen Cao (Naval Medical University), Editor-in-Chief; Professor Masao Omata (University of Tokyo), Honorary Editor-in-Chief; Professor Kai-Chun Wu (Fourth Military Medical University), Associate Editor; Professor Osamu Yokosuka (Chiba University), Associate Editor; Professor Kenneth Siu Ho Chok (University of Hong Kong), Associate Editor, etc.
Key Discussions during the meeting included:
Why does HCV SVR following DAA Treatment also Develop HCC (by Prof. Masao Omata)
The Role of Forkhead Box Transcription Factors in Hepatocellular Carcinoma Metastasis (by Prof. Kai-Chun Wu)
Recent Therapies for Advanced Hepatocellular Carcinoma (by Prof. Osamu Yokosuka )
Liver Cancer Staging and Prognosis (by Dr. Kenneth Siu Ho Chok)
Speaker: Prof. Masao Omata, Department of Gastroenterology, University of Tokyo
Speaker: Prof. Kenneth Siu Ho Chok, Department of Surgery, University of Hong Kong
In the afternoon, Professor Guang-Wen Cao, the Editor-in-Chief, held a discussion on the journal development and hot topics in liver cancer. The progress made in the past year has been highly praised by Professor Masao Omata, the Honorary Editor-in-Chief, who expressed his confidence in the promising future of HR.
Prof. Cao and other EBMs in discussion on the journal development
Prof. Cao reported on the achievements made during the year
The meeting was concluded with remarks by Professor Cao on behalf of the editorial office, expressing sincere appreciation to the Editorial Board Members, who have made huge contributions to the journal. It is believed that, HR would provide to its readers and authors an academic exchange platform of higher quality, under the guidance of Editors-in-Chief and Honorary Editors-in-Chief, with the cooperation of editorial board members and the efforts of each editor.
Members of the Editorial Board in the meeting
(From lower left:
Jin-Hua Hu, 302 Military Hospital of China, Beijing, China.
Yong Liao, Chongqing Medical University, Chongqing, China.
Osamu Yokosuka, Graduate School of Medicine, Chiba University, Chiba, Japan.
Masao Omata, University of Tokyo, Tokyo, Japan.
Kai-Chun Wu, Fourth Military Medical University, Xi'an, China.
Guang-Wen Cao, Naval Medical University, Shanghai, China.
Kenneth Siu Ho Chok, University of Hong Kong, Hongkong, China.
Yan Wang, Southern Medical University, Guangzhou, Guangdong, China.
Li-Yi Huang, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
From upper left:
Li-Min Xia, Fourth Military Medical University, Xi'an, Shaanxi, China.
Jin-Liang Xing, Fourth Military Medical University, Xi'an, Shaanxi, China.
Hong-Wei Zhang, Military Medical University of Navy, Shanghai, China.
Rong-Qian Wu, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Jun Li, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Bang-De Xiang, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Nan Li, Second Military Medical University, Shanghai, China.
Fu Yang, Second Military Medical University, Shanghai, China.
The team of Yong-Zhan Nie , Fourth Military Medical University, Xi'an, Shaanxi, China.)